Umbralisib (TGR-1202) sulfate, an orally active compound, serves as a potent, selective inhibitor targeting both PI3Kdelta and casein kinase-1-epsilon (CK1epsilon), with EC50 values of 22.2 nM and 6.0 µM, respectively. It demonstrates unique immunomodulatory effects on